{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:54:52Z","timestamp":1789948492326,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,8,1]],"date-time":"1995-08-01T00:00:00Z","timestamp":807235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[1995,8]]},"DOI":"10.1016\/0166-3542(95)00022-e","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:29:52Z","timestamp":1027657792000},"page":"389-404","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of the non-specific humoral and cellular antiviral immunity stimulated by the chloroform-methanol residue (CMR) fraction of Coxiella burnetii"],"prefix":"10.1016","volume":"27","author":[{"given":"M","family":"ZVILICH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"WILLIAMS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"WAAG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"RILL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"MALLI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"BELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"KENDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0166-3542(95)00022-E_BIB1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.266.10.1375","article-title":"The interferons","volume":"266","author":"Baron","year":"1991","journal-title":"J. Am. Med. Assoc."},{"issue":"suppl. A","key":"10.1016\/0166-3542(95)00022-E_BIB2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/14.suppl_A.27","article-title":"In vivo activity of antivirals against exotic RNA viral infections","volume":"14","author":"Canonico","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/0166-3542(95)00022-E_BIB3","first-page":"319","article-title":"Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii Infect","volume":"24","author":"Clark","year":"1979","journal-title":"Immun."},{"key":"10.1016\/0166-3542(95)00022-E_BIB4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/IAI.47.1.149-156.1985","article-title":"Suppression of in vitro lymphocyte proliferation in C57BL10 ScN mice vaccinated with phase I Coxiella burnetii","volume":"47","author":"Damrow","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/0166-3542(95)00022-E_BIB5","series-title":"Lymphokines and Interleukins","first-page":"190","article-title":"Interferon \u03b3","author":"Dawson","year":"1991"},{"key":"10.1016\/0166-3542(95)00022-E_BIB6","series-title":"Interferons and other regulatory cytokines","first-page":"246","article-title":"Production of IFN-\u03b3 by T cells and modulation of T cell, B cell and NK cell activity by interferons","author":"DeMaeyer","year":"1988"},{"key":"10.1016\/0166-3542(95)00022-E_BIB7","first-page":"65","article-title":"Rift Valley fever","volume":"10","author":"Easterday","year":"1965","journal-title":"Adv. Vet. Sci."},{"key":"10.1016\/0166-3542(95)00022-E_BIB8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/IAI.61.4.1251-1258.1993","article-title":"Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever","volume":"61","author":"Fries","year":"1993","journal-title":"Infect. Immun."},{"key":"10.1016\/0166-3542(95)00022-E_BIB9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0008-8749(77)80020-8","article-title":"Activation of guinea pig macrophages by Q-fever rickettsiae","volume":"28","author":"Kelly","year":"1977","journal-title":"Cell Immunol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00205464","article-title":"Tumor regression with Q-fever rickettsia and mycobacterial glycolipid","volume":"1","author":"Kelly","year":"1976","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/0166-3542(95)00022-E_BIB11","first-page":"51","article-title":"Treatment of experimental viral infections with immunomodulators","volume":"68","author":"Kende","year":"1988","journal-title":"Adv. Biosci."},{"key":"10.1016\/0166-3542(95)00022-E_BIB12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4049\/jimmunol.135.2.1067","article-title":"Cellular immunity in Q-fever: modulation of responsiveness by a suppressor T cell-monocyte circuit","volume":"135","author":"Koster","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB13","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.136.12.4525","article-title":"Bacterial lipopolysaccharide-induced IFN-\u03b3 production: roles of interleukin-1 and interleukin-2","volume":"136","author":"Le","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","article-title":"Rift Valley fever epizootic in Egypt 1977\u20131978. I. Description of the epizootic and virological studies","volume":"73","author":"Meegan","year":"1979","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/0166-3542(95)00022-E_BIB15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.49.3.748-753.1984","article-title":"Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with Influenza virus and Rubella virus vaccines","volume":"49","author":"Penn","year":"1984","journal-title":"J. Virol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4049\/jimmunol.121.2.543","article-title":"Macrophage activation for tumor cytotoxicity: control of macrophage tumoricidal capacity by the Lps gene","volume":"121","author":"Ruco","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/jir.1981.1.587","article-title":"Monitoring of interferon therapy by assay of (2\u2032-5\u2032) oligoadenylate synthetase in human peripheral white cells","volume":"1","author":"Schattner","year":"1981","journal-title":"J. Interferon Res."},{"key":"10.1016\/0166-3542(95)00022-E_BIB18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jlb.48.2.183","article-title":"Macrophages from C3HHeJ mice require an additional step to produce monokines: synergistic effects of silica and Poly(I:C) in the release of interleukin 1","volume":"48","author":"Souvannavong","year":"1990","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.iy.09.040191.001415","article-title":"The dendritic cell system and its role in immunogenicity","volume":"9","author":"Steinman","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.38.2.681-685.1982","article-title":"Silica enhancement of murine endotoxin sensitivity","volume":"38","author":"Vogel","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/0166-3542(95)00022-E_BIB21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.36.1.1","article-title":"Use of immune modulators in nonspecific therapy of bacterial infections","volume":"36","author":"Vogels","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/0166-3542(95)00022-E_BIB22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/08923978809014335","article-title":"Immune modulation by Coxiella burnetii: characterization of a phase I immunosuppressive complex differentially expressed among strains","volume":"10","author":"Waag","year":"1988","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1749-6632.1990.tb42221.x","article-title":"Injection of inactivated phase I Coxiella burnetii increases non-specific resistance to infection and stimulates lymphokine production in mice","volume":"590","author":"Waag","year":"1990","journal-title":"Ann. New York Acad. Sci."},{"key":"10.1016\/0166-3542(95)00022-E_BIB24","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.4049\/jimmunol.130.4.1770","article-title":"Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production","volume":"130","author":"Walker","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/0166-3542(95)00022-E_BIB25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/IAI.35.3.1091-1102.1982","article-title":"Biological and immunological properties of Coxiella burnetii vaccines in C57BL10 ScN endotoxin-nonresponder mice","volume":"35","author":"Williams","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/0166-3542(95)00022-E_BIB26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/IAI.32.2.840-851.1981","article-title":"Immunological and biological characterization of Coxiella burnetii, phases I and II, separated from host components","volume":"32","author":"Williams","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/0166-3542(95)00022-E_BIB27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/IAI.51.3.851-858.1986","article-title":"Characterization of a Phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q-Fever in C57BL10 ScN mice","volume":"51","author":"Williams","year":"1986","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/0166-3542(95)00022-E_BIB28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0166-3542(95)00003-5","article-title":"Efficacy of Coxiella burnetii and its chloroform-methanol residue (CMR) fraction against Rift Valley fever virus infection in mice","volume":"27","author":"Zvilich","year":"1995","journal-title":"Antiviral Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:016635429500022E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:016635429500022E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T22:03:56Z","timestamp":1681855436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/016635429500022E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,8]]}},"alternative-id":["016635429500022E"],"URL":"https:\/\/doi.org\/10.1016\/0166-3542(95)00022-e","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[1995,8]]}}}